Company intelligence / Profile preview

Xiaozheng Shu

Changzhou, Jiangsu, Chinapmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Other

Overview

BioRegen has developed and commercialized novel biomedical materials for wound repair with successful market entry in over 50 countries. Its products are used postoperatively in ENT, gynecology, and general surgery specialties with demonstrated clinical utility for tissue regeneration and adhesion prevention

Therapeutic areas: DermatologyWomen's HealthOther
Modalities: Biomaterial-based medical devicesDrug sustained release agents
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Xiaozheng Shu.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaozheng Shu.

Explore the full profile